Development of prohibitin ligands against osteoporosis

Authors: Tabti, Redouane, Lamoureux, François, Charrier, Céline, Ory, Benjamin, Heymann, Dominique, Bentouhami, Embarek, Désaubry, Laurent

Source: In European Journal of Medicinal Chemistry 15 January 2021 210

SFPH proteins as therapeutic targets for a myriad of diseases

Authors: Wang, Dong, Tabti, Redouane, Elderwish, Sabria, Djehal, Amel, Chouha, Nora, Pinot, Franck, Yu, Peng, Nebigil, Canan G., Désaubry, Laurent

Source: In Bioorganic & Medicinal Chemistry Letters 15 November 2020 30(22)

Prohibitin, STAT3 and SH2D4A physically and functionally interact in tumor cell mitochondria

Authors: Ploeger, Carolin, Huth, Thorben, Sugiyanto, Raisatun Nisa, Pusch, Stefan, Goeppert, Benjamin, Singer, Stephan, Tabti, Redouane, Hausser, Ingrid, Schirmacher, Peter, Désaubry, Laurent, Roessler, Stephanie

Source: Cell death and disease. 11(11)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190774895.0x000001&indx=1&recIds=ETOCvdc_100190774895.0x000001

Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases.

Authors: Wang, Dong¹ (AUTHOR), Tabti, Redouane² (AUTHOR), Elderwish, Sabria² (AUTHOR), Abou-Hamdan, Hussein² (AUTHOR), Djehal, Amel^2,3 (AUTHOR), Yu, Peng¹ (AUTHOR), Yurugi, Hajime⁴ (AUTHOR), Rajalingam, Krishnaraj⁴ (AUTHOR), Nebigil, Canan G.² (AUTHOR), Désaubry, Laurent^1,2 (AUTHOR) desaubry@unistra.fr

Source: Cellular & Molecular Life Sciences. Sep2020, Vol. 77 Issue 18, p3525-3546. 22p. 20 Diagrams, 1 Chart.

Subject Terms: *NEUROLOGICAL disorders, *HEART diseases, *SCAFFOLD proteins, *LIGANDS (Biochemistry), *CANCER, *PROGRAMMED cell death 1 receptors